Seroprevalence of celiac disease among United Arab Emirates healthy adult nationals: A gender disparity

Table 2 Distribution and association of variables according to celiac disease serology in Emiratis distribution n (%)

Variable		CD-ve	CD+ve	1OR (95%CI) [P value]	2OR (95%CI) [P value]
CD in family	No3	1181 (99.8)	14 (100)	0.998 (0.99-1.00)	-
	Yes	2 (0.2)	0 (0.0)	[0.828]
Anemia	No3	1097 (92.7)	9 (64.3)	7.09 (2.32-21.61)	4.58 (1.45-14.48)
	Yes	86 (7.3)	5 (35.7)	[0.003]	[0.01]
Headache	No3	1171 (99.0)	14 (100)	0.997 (0.99-1.00)	-
	Yes	12 (1.0)	0 (0.0)	[0.594]
Diarrhea	No3	1178 (99.6)	14 (100)	0.99 (0.98-1.00)	-
	Yes	5 (0.4)	0 (0.0)	[0.731]
Diabetes	No3	1162 (98.2)	14 (100)	0.996 (0.99-1.00)	-
	Yes	21 (1.7)	0 (0.0)	[0.480]
Tumor	No3	1182 (99.9)	14 (100)	0.98 (0.97-0.99)	-
	Yes	1 (0.1)	0 (0.0)	[0.878]
Thyroid disorder	No3	1175 (99.3)	13 (92.9)	11.30 (1.32-96.95)	-
	Yes	8 (0.7)	1 (7.1)	[0.09]
Hepatitis	No3	1172 (99.1)	14 (100)	0.998 (0.99-1.00)	-
	Yes	11 (0.9)	0 (0.0)	[0.610]
Sex	Man3	623 (52.7)	1 (7.1)	14.46 (1.89-110.91)	10.47 (1.33-82.14)
	Woman	560 (47.3)	13 (92.9)	[0.001]	[0.026]

¹Crude odd ratio; ²Adjusted odd ratio;

³Reference group. CD: Celiac disease.